Proposal to list medical devices supplied by Paragon Care Group New Zealand Limited
Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.
What we’re proposing
Pharmac is seeking feedback on a proposal to list medical devices supplied by Paragon Care Group New Zealand Limited (“Paragon”) in Part III of Section H of the Pharmaceutical Schedule from 1 December 2022 in the following categories:
- Electrocardiogram equipment and accessories (“cardiology equipment”); and
- Medical imaging, software and associated products (“medical imaging”).
Consultation closes at 4pm Thursday 20 October 2022 and feedback can be emailed to firstname.lastname@example.org.
What would the effect be?
From 1 December 2022 medical devices supplied Paragon would be listed under proposed national agreements for all Te Whatu Ora Hospitals to purchase under, subject to consultation and approval by Pharmac’s board or delegate (“Agreements”).
The Agreement would not be for sole supply and Te Whatu Ora Hospitals can continue to purchase other suppliers’ brands of electrocardiogram equipment and accessories and medical imaging, software and associated products.
The Agreement would supersede any existing Te Whatu Ora agreements with Paragon for the medical devices included in the Agreement. Any medical device listed in the Agreement and purchased by Te Whatu Ora would be in accordance with the terms and conditions, including price, stated in the Agreements effective from the date of listing in the Pharmaceutical Schedule.
Pricing for the medical devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- Te Whatu Ora clinical staff in a range of different clinical settings including but not limited to:
- Cardiac Physiologists and Perfusionists
- Maternity Care Specialists
- Clinical engineers and maintenance services
- Procurement and supply chain personnel
- Suppliers and wholesalers
About the medical devices
Electrocardiogram equipment and accessories
The electrocardiogram equipment and accessories category include medical devices used to collect, measure and interpret the electrical activity of the heart. This includes electrocardiogram monitors, holter monitors and associated accessories (such as gels, electrodes and leads).
Medical imaging is the technique and process of imaging the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues.
Why we’re proposing this
Pharmac has previously released procurement processes for the non-exclusive national agreements for listing on the Pharmaceutical Schedule:
- supply of electrocardiogram equipment and accessories
- supply of medical imaging equipment, associated consumables, accessories, software and services and maintenance(external link)
Pharmac has been working with suppliers who responded to the procurement processes to seek provisional agreements. This proposal consists of the latest agreement to arise from these processes and we expect to consult on further provisional agreements with suppliers in this category throughout 2022.
Details about our proposal
Pharmac has entered into a provisional agreement with Paragon for the supply of electrocardiogram equipment and accessories and medical imaging, software and associated products.
The proposal would result in Pharmaceutical Schedule listings for:
Backpad, Dynatrace, Cleartrace, Dynatrace, E-trode, Heartbeat, Huggables, Multifunction, Neotrode, Positrace, Softrace, Suretrace and Universal adapter
Further information, including pricing and contractual details, has been provided to Te Whatu Ora Procurement personnel. Clinicians interested in further detail on what this change means for their Te Whatu Ora Hospital should engage with their Procurement teams.
To provide feedback
Send us an email: email@example.com by 4pm 20 October 2022.
All feedback received before the closing date will be considered by PHARMAC’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.
We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.